Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2023 Financial Results on February 6, 2024

Rhea-AI Summary

Inspire Medical Systems, Inc. (NYSE: INSP) will release financial results for the fourth quarter and fiscal 2023 after the close of trading on Tuesday, February 6. The management team will host a conference call to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website.

MINNEAPOLIS, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2023 after the close of trading on Tuesday, February 6. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q4 2023 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q4 2023 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems release financial results for the fourth quarter and fiscal 2023?

Inspire Medical Systems will release financial results after the close of trading on Tuesday, February 6.

How can I access the webcast of Inspire's Q4 2023 earnings call?

The webcast will be accessible via the Investor Relations page of the Inspire website or through a provided link.

What should I do if I plan to ask a question during the earnings call?

If you plan to ask a question, please use the provided link to register and receive dial-in details and a unique conference call access code.

When will the replay of the earnings call be available?

A replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.